The fibrin-specific plasminogen activator – which is already sold as Metalyse and TNKase for patients with suspected acute myocardial infarction – was being tested in phase 3 stroke trials ...

An acute ischemic stroke is potentially manageable with a number of medical treatments, including a powerful treatment using clot-dissolving drugs such as TNKase (tenecteplase) and other kinds of ...